	Israel Securities Authority			Tel Aviv Stock Exchange		C001 ( Public )		Reported via MAGNA:	30/05/2025
	www.isa.gov.il			www.tase.co.il				Reference:	2025-02-039511	Time of broadcast: 23:35 23:35

Report of Periodic or Interim Report

Regulation 3 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on

6k30052025_isa.pdf

Link to filing on foreign stock exchange (optional): _________


References of previous documents relating to this matter(the reference does not constitute incorporation by reference):



Stock Exchange/Market: -1	Date of revision of form structure: 06/08/2024
Address: Einstein 14 , NES-ZIONA 7403618 , ISRAEL Tel: 02-6708072 , Fax: 02-6708070
E-mail address: shachar@enlivexpharm.com Company site: www.enlivex.com

Previous names of reporting entity:

Name of the Signatory: SHLOSBERGER SHACHAR Position of Signatory in the reporting corporation: Chief Financial Officer Name of Employer Company: Enlivex thetraputics R
Address: Einstein 14 , nez ziona 7403618 Telephone: 02-6208072 Facsimile: E-mail: shachar@enlivexpharm.com 1
ISRAEL